Literature DB >> 10215301

Predictors of death from congestive heart failure in hypertrophic cardiomyopathy.

H Ikeda1, S Maki, N Yoshida, T Murohara, H Adachi, Y Koga, T Imaizumi.   

Abstract

In 309 patients with hypertrophic cardiomyopathy during long-term follow-up (mean 9.4 years), independent predictors of death from congestive heart failure (n = 15) were smaller electrocardiographic SV1 + RV5 and smaller echocardiographic fractional shortening at the initial evaluation. Our data may contribute to the construction of therapeutic strategies for the prevention of heart failure death in patients with hypertrophic cardiomyopathy.

Entities:  

Mesh：

Year:  1999        PMID： 10215301

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  4 in total

1.  Heterogeneity of longitudinal and circumferential contraction in relation to late gadolinium enhancement in hypertrophic cardiomyopathy patients with preserved left ventricular ejection fraction.

Authors:  Keita Sakamoto; Noriko Oyama-Manabe; Osamu Manabe; Tadao Aikawa; Yasuka Kikuchi; Harue Sasai-Masuko; Masanao Naya; Kohsuke Kudo; Fumi Kato; Nagara Tamaki; Hiroki Shirato
Journal:  Jpn J Radiol       Date:  2017-11-09       Impact factor: 2.374

2.  Aborted sudden cardiac death (SCD) in a patient with hypertrophic cardiomyopathy (HCM) with low-risk factors for SCD.

Authors:  Sashank Kaushik; Stalin Ramakrishnan Subramanian; Shahrokh Rafii; Ricardo Castillo
Journal:  BMJ Case Rep       Date:  2013-01-25

3.  Do myocardial perfusion SPECT and radionuclide angiography studies in adult patients with hypertrophic cardiomyopathy have prognostic implications?

Authors:  Guillermo Romero-Farina; Jaume Candell-Riera; Enrique Galve; Lluís Armadans; Francisca Ramos; Joan Castell; Santiago Aguadé; Juan M Nogales; Jordi Soler-Soler
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

4.  Echocardiographic predictors of severe heart failure symptoms in hypertrophic cardiomyopathy patients with sinus rhythm.

Authors:  Fatih Bayrak; Gokhan Kahveci; Muzaffer Degertekin; Bulent Mutlu
Journal:  Trials       Date:  2008-02-29       Impact factor: 2.279
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.